Advanced glycosylation end products inhibit the proliferation of bone-marrow stromal cells through activating MAPK pathway

Abstract

Background The purpose of present study was to explore the mechanism of nuclear factor-kappa B (NF-κB), phosphatidylinositol 3-kinase (PI3K)/protein kinase B(PKB/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways after intervention of advanced glycosylation end products (AGEs) on rat bone-marrow stromal cells (BMSCs). Methods Prepare and identify AGEs. BMSCs were isolated from 16 SD rats and cultured with different concentration of AGEs. Cell viability was detected by cell counting kit-8 (CCK-8). BMSCs were cultured with AGEs (0.25 mg/ml) for 30 min, 12 h, 24 h, 72 h and 120 h. In addition, BMSCs were cultured with AGEs, AGEs + JNK inhibitor and AGEs + P38 inhibitor for 24 h and 48 h, respectively. Western blotting and RT-PCR were used to determine the protein and mRNA expression levels, respectively. Results Cell viability of BMSCs was significantly correlated with concentration and effect time of AGEs (P < 0.05), and the most appropriate concentration was 0.25 mg/ml. AGEs stimulation significantly increased the protein expression levels of NF-κB p65, JNK, p38 (P < 0.05), decreased IκB (P < 0.05), but had no effect on the protein expression of Akt in BMSCs (P > 0.05). At the mRNA level, JNK and p38 inhibitors significantly reduced the levels of NF-κB p65, p38 and JNK, increased IκB (P > 0.05), but had no effect on Akt in BMSCs (P > 0.05). At the protein level, JNK and p38 inhibitors notably decreased the expression of NF-κB p65, p38, p-JNK, P-IκB and JNK (P < 0.001), and increased IκB (P < 0.05). Conclusion Advanced glycosylation end products can inhibit the proliferation of bone-marrow stromal cells through activating MAPK pathway.

Mangiferin Alleviates Postpartum Depression–Like Behaviors by Inhibiting MAPK Signaling in Microglia

“…Moreover, treatment with MGF significantly inhibited the increase in microglial number in the hippocampus, suggesting that the neuroprotective role of MGF might be associated with its inhibitory effect on microglial activation. To further elucidate the potential targets of MGF, we performed bioinformatics analysis and found that MGF targets MAPK signaling, which regulates cell proliferation, stress response, inflammation, cell differentiation, and apoptosis (Li Z et al, 2021;Qin et al, 2021;Wang et al, 2021;Yang et al, 2021). More importantly, the MAPK signal pathway has been linked to several diseases, including depression (Duman et al, 2007;Wang and Mao, 2019;Humo et al, 2020).…”

Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia

“…High glucose environments can induce alterations in the expression levels of various signaling molecules, which impact the osteogenic differentiation of BMSCs through signal transduction, gene expression, as well as immune regulation. The most widely studied mechanisms that underlie HG-mediated BMSCs osteogenesis include ROS overproduction ( 97 , 98 ), AGEs-RAGEs signaling axis ( 99 ), and immunomodulation ( 100 , 101 ). etc.…”

A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment

“…Hyperglycemia is the most apparent clinical manifestation in diabetes mellitus, and excess free sugars in the body adversely affect many tissues and cells. High levels of extracellular free sugars have a direct inhibitory effect on the cellular activity of, both, osteoblasts and osteocytes ( 54 , 55 ). Osteoblasts exposed to high glucose levels exhibit reduced proliferation capacity, slow extracellular matrix synthesis, and subsequently slow maturation and mineralization.…”